Red-light therapy for dementia with Lewy bodies
Part of Brain & nervous system, Mental health clinical trials.
This study tests if red-light therapy on the head can improve symptoms and daily life for people with dementia with Lewy bodies. It also looks at how the therapy affects brain activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older
- You have a diagnosis of probable or prodromal dementia with Lewy bodies
- You score 18 or higher on a recent memory test (MMSE)
- You have a caregiver or loved one who can join you
- Your head circumference is between 54 and 62 cm
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain changes affect attention and thinking in people with Lewy body dementia. It includes brain scans, an EEG, and a medication option to see if it helps with symptoms.
This study tests whether a gentle brain stimulation technique called tDCS (transcranial direct current stimulation) can help reduce psychotic symptoms, like hallucinations, in people with dementia with Lewy bodies. It also looks at how this might ease the day-to-day burden on caregivers.
This trial tests whether ambroxol (a mouth medicine) can help people with new or early dementia with Lewy bodies (DLB) or mild cognitive impairment linked to DLB. Participants take the medicine for about 18 months while the study tracks safety and changes over time.
This trial tests a noninvasive magnetic brain stimulation (rTMS) treatment for people with dementia with Lewy bodies. The treatment aims to help improve thinking and memory. It involves 1–2 weeks of daily sessions, and you'll have memory tests and brain scans during the study.
This trial tests whether light therapy can improve behavioral and psychological symptoms (such as agitation or aggression) in people with dementia. You may be eligible if you or your loved one is admitted to a specific inpatient unit at Mayo Clinic and has these symptoms.
This study tests a type of light therapy (called transcranial photobiomodulation) to see if it can help people with early-stage Alzheimer's. It involves coming to Cedars-Sinai for weekly sessions over a period of time.
Hear when a new Photobiomodulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.